| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.584 | 0.019 | 0.584 | Immunostimulant | 0.474 0.033 DBMET03214 0.429 0.042 DBMET03035 0.309 0.076 DBMET03036 0.28 0.085 DB15686 | ||
| 0.476 | 0.012 | 0.537 | RNA-directed DNA polymerase inhibitor | 0.537 0.009 DBMET03214 0.497 0.011 DBMET03035 0.201 0.099 DBMET03215 0.463 0.013 DBMET03036 0.401 0.018 DB15686 | DBMET03214 | |
| 0.436 | 0.002 | 0.497 | HCV NS5B polymerase inhibitor | 0.497 0.002 DBMET03214 0.251 0.003 DBMET03035 0.098 0.005 DBMET03036 0.053 0.009 DB15686 | DBMET03214 | |
| 0.403 | 0.109 | 0.497 | Caspase 9 stimulant | 0.497 0.061 DBMET03214 0.335 0.158 DBMET03035 | DBMET03214 | |
| 0.318 | 0.072 | 0.417 | Immunomodulator | 0.417 0.039 DBMET03214 0.394 0.046 DBMET03035 0.194 0.172 DBMET03215 0.316 0.074 DBMET03036 0.337 0.064 DB15686 | DBMET03214 | |
| 0.234 | 0.008 | 0.234 | Antimetabolite | 0.212 0.009 DBMET03214 0.173 0.011 DBMET03035 0.066 0.023 DBMET03036 0.049 0.032 DB15686 | ||
| 0.157 | 0.014 | 0.179 | Transcription factor NF kappa B stimulant | 0.179 0.011 DBMET03214 0.147 0.016 DBMET03035 0.09 0.051 DBMET03215 0.129 0.021 DBMET03036 0.122 0.024 DB15686 | DBMET03214 | |
| 0.15 | 0.021 | 0.15 | Toll-Like receptor 4 antagonist | 0.128 0.036 DBMET03214 0.116 0.047 DBMET03035 0.094 0.081 DBMET03036 | ||
| 0.159 | 0.039 | 0.267 | Adenylate cyclase inhibitor | 0.149 0.045 DBMET03214 0.164 0.037 DBMET03035 0.267 0.017 DBMET03036 0.183 0.029 DB15686 | DBMET03036 | |
| 0.116 | 0.004 | 0.129 | Antiviral (Hepatitis D) | 0.129 0.004 DBMET03214 0.11 0.004 DBMET03035 0.052 0.032 DBMET03215 0.074 0.011 DBMET03036 0.047 0.044 DB15686 | DBMET03214 | |
| 0.213 | 0.104 | 0.452 | DNA synthesis inhibitor | 0.206 0.114 DBMET03214 0.277 0.052 DBMET03035 0.248 0.067 DBMET03215 0.452 0.017 DBMET03036 0.407 0.021 DB15686 | DBMET03036 | |
| 0.125 | 0.016 | 0.125 | Ribonucleotide reductase inhibitor | 0.102 0.02 DBMET03214 0.074 0.029 DBMET03035 | ||
| 0.154 | 0.047 | 0.404 | DNA polymerase I inhibitor | 0.156 0.046 DBMET03214 0.174 0.038 DBMET03035 0.129 0.062 DBMET03215 0.404 0.006 DBMET03036 0.217 0.023 DB15686 | DBMET03036 | |
| 0.115 | 0.016 | 0.115 | Ribonucleoside-diphosphate reductase inhibitor | 0.091 0.021 DBMET03214 0.065 0.032 DBMET03035 | ||
| 0.242 | 0.155 | 0.38 | Immunosuppressant | 0.217 0.18 DBMET03035 0.38 0.072 DBMET03036 0.304 0.112 DB15686 | DBMET03036 | |
| 0.118 | 0.038 | 0.148 | DNA directed RNA polymerase inhibitor | 0.148 0.024 DBMET03214 0.121 0.036 DBMET03035 0.143 0.026 DBMET03036 | DBMET03214 | |
| 0.063 | 0.009 | 0.076 | RNA-directed RNA polymerase inhibitor | 0.076 0.007 DBMET03214 0.034 0.025 DBMET03035 | DBMET03214 | |
| 0.097 | 0.049 | 0.239 | Aminoacyl-tRNA synthetase inhibitor | 0.092 0.055 DBMET03214 0.104 0.041 DBMET03035 0.239 0.009 DBMET03036 0.125 0.028 DB15686 | DBMET03036 | |
| 0.247 | 0.217 | 0.285 | Apoptosis agonist | 0.285 0.183 DBMET03214 | DBMET03214 | |
| 0.171 | 0.146 | 0.243 | Hypoglycemic | 0.173 0.143 DBMET03214 0.205 0.107 DBMET03035 0.243 0.081 DB15686 | DB15686 | |
| 0.031 | 0.017 | 0.085 | Purinergic P2X agonist | 0.036 0.014 DBMET03214 0.04 0.013 DBMET03035 0.032 0.016 DBMET03215 0.085 0.004 DBMET03036 0.037 0.014 DB15686 | DBMET03036 | |
| 0.016 | 0.009 | 0.021 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.018 0.008 DBMET03214 0.017 0.008 DBMET03035 0.014 0.013 DBMET03215 0.016 0.009 DBMET03036 0.021 0.006 DB15686 | DB15686 | |
| 0.015 | 0.017 | 0.03 | Adenosine A3 receptor agonist | 0.016 0.013 DBMET03214 0.018 0.011 DBMET03035 0.017 0.012 DBMET03215 0.022 0.007 DBMET03036 0.03 0.005 DB15686 | DB15686 | |
| 0.011 | 0.015 | 0.046 | Purinergic P2 agonist | 0.013 0.012 DBMET03214 0.014 0.012 DBMET03035 0.046 0.003 DBMET03036 | DBMET03036 | |
| 0.011 | 0.015 | 0.046 | Purinergic receptor agonist | 0.013 0.012 DBMET03214 0.014 0.012 DBMET03035 0.046 0.003 DBMET03036 | DBMET03036 | |
| 0.009 | 0.014 | 0.039 | Purinergic P2Y agonist | 0.039 0.003 DBMET03036 | DBMET03036 | |
| 0.018 | 0.025 | 0.039 | Adenosine A1 receptor agonist | 0.023 0.018 DBMET03035 0.037 0.008 DBMET03036 0.039 0.008 DB15686 | DB15686 | |
| 0.03 | 0.039 | 0.052 | Antibiotic Aminoglycoside-like | 0.033 0.031 DBMET03035 0.033 0.03 DBMET03215 0.041 0.02 DBMET03036 0.052 0.012 DB15686 | DB15686 | |
| 0.185 | 0.195 | 0.22 | Caspase 3 stimulant | 0.22 0.143 DBMET03214 | DBMET03214 | |
| 0.013 | 0.026 | 0.04 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.04 0.006 DBMET03036 | DBMET03036 | |
| 0.001 | 0.017 | 0.004 | Purinergic P2Y4 agonist | 0.004 0.003 DBMET03036 | DBMET03036 | |
| 0.009 | 0.034 | 0.018 | Adenosine A2b receptor agonist | 0.014 0.011 DBMET03036 0.018 0.007 DB15686 | DB15686 | |
| 0.027 | 0.052 | 0.044 | Tubulin agonist | 0.032 0.03 DBMET03035 0.035 0.022 DBMET03215 0.038 0.018 DBMET03036 0.044 0.012 DB15686 | DB15686 | |
| 0.043 | 0.069 | 0.185 | Purinergic P2X2 antagonist | 0.069 0.046 DBMET03214 0.086 0.037 DBMET03035 0.185 0.006 DBMET03036 0.089 0.035 DB15686 | DBMET03036 | |
| 0.044 | 0.069 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.035 DBMET03035 | DBMET03035 | |
| 0.005 | 0.034 | 0.016 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.016 0.009 DBMET03035 | DBMET03035 | |
| 0.027 | 0.056 | 0.062 | Endothelin-converting enzyme inhibitor | 0.062 0.024 DBMET03035 | DBMET03035 | |
| 0.241 | 0.277 | 0.627 | Antiinflammatory | 0.263 0.252 DBMET03035 0.305 0.211 DBMET03215 0.526 0.077 DBMET03036 0.627 0.046 DB15686 | DB15686 | |
| 0.11 | 0.156 | 0.235 | Nitric oxide antagonist | 0.14 0.105 DBMET03036 0.235 0.056 DB15686 | DB15686 | |
| 0.032 | 0.087 | 0.205 | Argininosuccinate synthase inhibitor | 0.063 0.034 DBMET03035 0.205 0.007 DBMET03036 0.088 0.023 DB15686 | DBMET03036 | |
| 0.106 | 0.164 | 0.145 | Platelet adhesion inhibitor | 0.145 0.111 DBMET03036 | DBMET03036 | |
| 0.028 | 0.089 | 0.05 | Protein 50S ribosomal subunit inhibitor | 0.047 0.043 DBMET03036 0.05 0.04 DB15686 | DB15686 | |
| 0.048 | 0.113 | 0.231 | Glutamate dehydrogenase inhibitor | 0.079 0.045 DBMET03035 0.231 0.008 DBMET03036 0.114 0.024 DB15686 | DBMET03036 | |
| 0.03 | 0.103 | 0.065 | Selectin antagonist | 0.065 0.045 DB15686 | DB15686 | |
| 0.09 | 0.171 | 0.215 | Angiogenesis stimulant | 0.215 0.087 DB15686 | DB15686 | |
| 0.029 | 0.115 | 0.335 | Carbamoyl phosphate synthetase inhibitor | 0.063 0.04 DBMET03214 0.106 0.019 DBMET03035 0.335 0.004 DBMET03036 0.168 0.009 DB15686 | DBMET03036 | |
| 0.007 | 0.095 | 0.03 | Purinergic P2Y1 agonist | 0.03 0.004 DBMET03036 0.017 0.009 DB15686 | DBMET03036 | |
| 0.006 | 0.105 | 0.036 | Purinergic P2Y1 antagonist | 0.036 0.004 DBMET03036 | DBMET03036 | |
| 0.047 | 0.149 | 0.092 | Phosphodiesterase VIII inhibitor | 0.079 0.037 DBMET03036 0.092 0.02 DB15686 | DB15686 | |
| 0.017 | 0.123 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET03036 | DBMET03036 | |
| 0.008 | 0.115 | 0.022 | Purinergic P2Y12 antagonist | 0.022 0.016 DBMET03036 | DBMET03036 | |
| 0.016 | 0.136 | 0.086 | Ornithine carbamoyltransferase inhibitor | 0.086 0.019 DBMET03036 | DBMET03036 | |
| 0.091 | 0.213 | 0.632 | Hepatoprotectant | 0.632 0.004 DBMET03215 | DBMET03215 | |
| 0.024 | 0.148 | 0.271 | Phosphofructokinase-1 inhibitor | 0.071 0.047 DBMET03035 0.271 0.006 DBMET03036 0.213 0.01 DB15686 | DBMET03036 | |
| 0.016 | 0.151 | 0.057 | Purinergic P2Y2 antagonist | 0.057 0.008 DBMET03036 | DBMET03036 | |
| 0.004 | 0.139 | 0.011 | Egl nine homolog 2 inhibitor | 0.011 0.009 DB15686 | DB15686 | |
| 0.004 | 0.14 | 0.058 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.058 0.007 DBMET03036 0.037 0.013 DB15686 | DBMET03036 | |
| 0.048 | 0.214 | 0.486 | NADH dehydrogenase inhibitor | 0.102 0.042 DBMET03214 0.145 0.019 DBMET03035 0.086 0.063 DBMET03215 0.486 0.003 DBMET03036 0.411 0.004 DB15686 | DBMET03036 | |
| 0.144 | 0.313 | 0.285 | Interleukin 2 agonist | 0.285 0.085 DB15686 | DB15686 | |
| 0.018 | 0.192 | 0.032 | Transforming growth factor beta 2 antagonist | 0.032 0.025 DB15686 | DB15686 | |
| 0.056 | 0.254 | 0.358 | Adenylate kinase inhibitor | 0.09 0.087 DBMET03214 0.125 0.04 DBMET03035 0.358 0.004 DBMET03036 0.212 0.013 DB15686 | DBMET03036 | |
| 0.103 | 0.313 | 0.447 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 DBMET03214 0.187 0.084 DBMET03035 0.447 0.005 DBMET03036 0.424 0.006 DB15686 | DBMET03036 | |
| 0.144 | 0.371 | 0.596 | Cyclophilin D inhibitor | 0.564 0.034 DBMET03215 0.385 0.099 DBMET03036 0.596 0.028 DB15686 | DB15686 | |
| 0.007 | 0.247 | 0.086 | Fumarate hydratase inhibitor | 0.086 0.006 DBMET03036 0.039 0.02 DB15686 | DBMET03036 | |
| 0.02 | 0.266 | 0.106 | Toll-Like receptor 7 antagonist | 0.086 0.032 DBMET03036 0.106 0.018 DB15686 | DB15686 | |
| 0.048 | 0.297 | 0.133 | Toll-Like receptor antagonist | 0.133 0.069 DB15686 | DB15686 | |
| 0.052 | 0.31 | 0.13 | Interleukin 4 antagonist | 0.13 0.072 DB15686 | DB15686 | |
| 0.008 | 0.279 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 DBMET03036 0.018 0.014 DB15686 | DBMET03036 | |
| 0.098 | 0.383 | 0.334 | Vasodilator, coronary | 0.277 0.107 DBMET03036 0.334 0.064 DB15686 | DB15686 | |
| 0.003 | 0.289 | 0.04 | Adenosine A2 receptor agonist | 0.016 0.011 DBMET03036 0.04 0.004 DB15686 | DB15686 | |
| 0.014 | 0.303 | 0.294 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.06 0.034 DBMET03035 0.294 0.004 DBMET03036 0.245 0.005 DB15686 | DBMET03036 | |
| 0.002 | 0.325 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 DBMET03036 | DBMET03036 | |
| 0.009 | 0.365 | 0.176 | Acyl-CoA dehydrogenase inhibitor | 0.176 0.007 DBMET03036 0.078 0.023 DB15686 | DBMET03036 | |
| 0.004 | 0.363 | 0.128 | Phosphoglycerate kinase inhibitor | 0.128 0.005 DBMET03036 0.101 0.007 DB15686 | DBMET03036 | |
| 0.01 | 0.37 | 0.089 | Adenosine deaminase inhibitor | 0.076 0.01 DBMET03036 0.089 0.007 DB15686 | DB15686 | |
| 0.02 | 0.385 | 0.176 | Purinergic P2X1 antagonist | 0.176 0.005 DBMET03036 0.094 0.019 DB15686 | DBMET03036 | |
| 0.024 | 0.418 | 0.083 | Uric acid excretion stimulant | 0.083 0.078 DB15686 | DB15686 | |
| 0.018 | 0.441 | 0.064 | Transforming growth factor antagonist | 0.064 0.059 DB15686 | DB15686 | |
| 0.013 | 0.452 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 DBMET03036 0.045 0.039 DB15686 | DBMET03036 | |
| 0.049 | 0.498 | 0.206 | Transcription factor NF kappa B inhibitor | 0.206 0.163 DB15686 | DB15686 | |
| 0.017 | 0.468 | 0.135 | TRKB antagonist | 0.135 0.057 DB15686 | DB15686 | |
| 0.025 | 0.486 | 0.12 | Protein kinase stimulant | 0.12 0.093 DB15686 | DB15686 | |
| 0.001 | 0.472 | 0.028 | Adenosine A2a receptor agonist | 0.028 0.006 DB15686 | DB15686 | |
| 0.005 | 0.48 | 0.053 | Phosphatidylinositol 3-kinase delta inhibitor | 0.053 0.044 DB15686 | DB15686 | |
| 0.049 | 0.539 | 0.242 | Cholesterol antagonist | 0.242 0.131 DB15686 | DB15686 | |
| 0.009 | 0.511 | 0.067 | AICAR transformylase inhibitor | 0.067 0.011 DBMET03036 0.045 0.028 DB15686 | DBMET03036 | |
| 0.004 | 0.519 | 0.086 | Purinergic P2Y antagonist | 0.086 0.011 DBMET03036 | DBMET03036 | |
| 0.006 | 0.549 | 0.184 | Biliverdin reductase inhibitor | 0.184 0.007 DBMET03036 0.081 0.026 DB15686 | DBMET03036 | |
| 0.014 | 0.587 | 0.265 | UDP-glucose 4-epimerase inhibitor | 0.265 0.012 DBMET03036 0.185 0.02 DB15686 | DBMET03036 | |
| 0.048 | 0.629 | 0.201 | MAP-kinase-activated kinase 5 inhibitor | 0.201 0.102 DB15686 | DB15686 | |
| 0.003 | 0.608 | 0.042 | Sodium/glucose cotransporter inhibitor | 0.042 0.006 DB15686 | DB15686 | |
| 0.003 | 0.618 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.016 DB15686 | DB15686 | |
| 0.015 | 0.635 | 0.1 | Xanthine oxidase inhibitor | 0.1 0.06 DB15686 | DB15686 | |
| 0.022 | 0.65 | 0.145 | Adenylate cyclase stimulant | 0.126 0.111 DBMET03036 0.145 0.072 DB15686 | DB15686 | |
| 0.04 | 0.676 | 0.16 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.16 0.131 DB15686 | DB15686 | |
| 0.025 | 0.664 | 0.254 | Angiogenesis inhibitor | 0.254 0.12 DBMET03036 0.214 0.154 DB15686 | DBMET03036 | |
| 0.002 | 0.649 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET03036 | DBMET03036 | |
| 0.025 | 0.676 | 0.186 | Phospholipase C inhibitor | 0.186 0.055 DBMET03036 | DBMET03036 | |
| 0.062 | 0.727 | 0.203 | Heat shock protein 70 antagonist | 0.203 0.006 DBMET03036 0.135 0.096 DB15686 | DBMET03036 | |
| 0.025 | 0.691 | 0.13 | Interferon gamma antagonist | 0.13 0.112 DB15686 | DB15686 | |
| 0.007 | 0.674 | 0.066 | Thymidine kinase inhibitor | 0.066 0.012 DBMET03036 0.057 0.015 DB15686 | DBMET03036 | |
| 0.001 | 0.682 | 0.038 | Adenosine kinase inhibitor | 0.038 0.008 DBMET03036 0.037 0.008 DB15686 | DBMET03036 | |
| 0.002 | 0.697 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DB15686 | DB15686 | |
| 0.02 | 0.721 | 0.615 | Antiobesity | 0.615 0.019 DBMET03215 | DBMET03215 | |
| 0.013 | 0.732 | 0.107 | Aldehyde dehydrogenase inhibitor | 0.107 0.087 DBMET03036 | DBMET03036 | |
| 0.012 | 0.75 | 0.089 | Triose-phosphate isomerase inhibitor | 0.089 0.061 DBMET03036 | DBMET03036 | |
| 0.005 | 0.767 | 0.077 | Interferon agonist | 0.077 0.057 DB15686 | DB15686 | |
| 0.002 | 0.768 | 0.132 | Adenosine A1 receptor antagonist | 0.132 0.018 DB15686 | DB15686 | |
| 0.005 | 0.789 | 0.063 | Interferon inducer | 0.063 0.047 DB15686 | DB15686 | |
| 0.021 | 0.806 | 0.161 | Interleukin agonist | 0.161 0.157 DB15686 | DB15686 | |
| 0.004 | 0.813 | 0.133 | Adenosine A3 receptor antagonist | 0.133 0.015 DB15686 | DB15686 | |
| 0.018 | 0.827 | 0.15 | DNA repair enzyme inhibitor | 0.15 0.031 DBMET03036 0.148 0.034 DB15686 | DBMET03036 | |
| 0.002 | 0.826 | 0.138 | Adenosine A2a receptor antagonist | 0.138 0.017 DB15686 | DB15686 | |
| 0.006 | 0.844 | 0.141 | Alpha-N-acetylglucosaminidase inhibitor | 0.141 0.06 DB15686 | DB15686 | |
| 0.002 | 0.842 | 0.129 | Adenosine A2 receptor antagonist | 0.129 0.02 DB15686 | DB15686 | |
| 0.014 | 0.855 | 0.101 | Amylase inhibitor | 0.101 0.096 DB15686 | DB15686 | |
| 0.004 | 0.869 | 0.133 | Mannose-6-phosphate isomerase inhibitor | 0.133 0.081 DBMET03036 | DBMET03036 | |
| 0.002 | 0.878 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.06 DB15686 | DB15686 | |
| 0.002 | 0.887 | 0.085 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.085 0.064 DB15686 | DB15686 | |
| 0.011 | 0.904 | 0.197 | Hexokinase inhibitor | 0.197 0.037 DBMET03036 0.157 0.07 DB15686 | DBMET03036 | |
| 0.006 | 0.902 | 0.188 | Cyclic AMP phosphodiesterase inhibitor | 0.188 0.103 DB15686 | DB15686 | |
| 0.008 | 0.944 | 0.146 | CF transmembrane conductance regulator agonist | 0.146 0.084 DB15686 | DB15686 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |